Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
about
The epigenetic landscape of acute myeloid leukemiaC/EBPα Dysregulation in AML and ALLA Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.Genetic predisposition syndromes: when should they be considered in the work-up of MDS?Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome.CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinomaFamilial aggregation of acute myeloid leukemia and myelodysplastic syndromesThe consensus sequence of FAMLF alternative splice variants is overexpressed in undifferentiated hematopoietic cellsRecognizing familial myeloid leukemia in adults.Genetic predispositions to childhood leukemia.Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family.Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigationsAdvances in the prognostication and management of advanced MDS in children.Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes.Familial leukemias.CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis.Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists.Acute myeloid leukaemia genomics.C/EBPα deregulation as a paradigm for leukemogenesis.Next-generation sequencing of cancer genomes: back to the future.The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia.Familial Myelodysplastic/Acute Leukemia Syndromes-Myeloid Neoplasms with Germline PredispositionCellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic AberrationsOverexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis.Clinical Assessment and Diagnosis of Germline Predisposition to Hematopoietic Malignancies: The University of Chicago Experience.Emerging molecular predictive and prognostic factors in acute myeloid leukemia.Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms.How I diagnose and manage individuals at risk for inherited myeloid malignancies.Genetic heterogeneity of cytogenetically normal AML with mutations ofChallenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine useWhen to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter
P2860
Q21284742-9F20A0E1-33C7-4EE6-A8C5-9701518C1040Q22065117-E4BE0847-EEE9-45CB-A0E8-3BA46E603E48Q30252766-B20132A3-D7AE-4813-A603-B91A1EFF0800Q33420216-01878851-DA51-482F-8352-5277DD113B59Q33428604-3408E1E4-797F-48DA-B79A-2D7549FF2B65Q34930673-07C56E34-E813-4448-91A6-74FFDAA299DAQ35194416-5D7D2D24-C4BF-4736-AB1E-0D600EDD7DD5Q35665103-C833482C-11B5-4D63-AE6F-4F15A7A8D1B4Q35666425-03CF4E71-0216-47E0-A5FD-9B5EE1B75A1FQ37073883-9FD66FB9-AC02-4BBC-B315-FC5A27B7429BQ37073895-7FA6E0BE-F500-437D-BE3C-85CC1C195D8CQ37216459-30B45484-BE1E-48E1-A730-44A7793E9C6BQ37652896-902779FC-3C66-4788-80E0-62AFBF30B8A3Q37873542-00D0B350-5941-4594-B6AE-BE03544CBBDBQ38018130-1488A94C-2E6F-437E-94E6-E86B234CFF0DQ38374412-FD061D52-22A9-4C00-9515-767A3FE13F31Q38884580-C93A1146-7CB8-4727-A01F-11A4FD0CEB3EQ39000607-C666C657-894D-4FA9-AA92-ADF81F75ED4DQ39400164-39497372-D084-4FA1-8438-36BB8E2EEFC9Q39442731-8EB7C3CF-0DB8-4200-8A8B-C010C36CFBD2Q39900008-A8A88BA6-D1F9-4B0A-92A9-3D3B36ABA980Q39903788-DFBDC8D4-5165-4408-8F90-663A0E2ED0D9Q41684390-0F696F2F-CE5A-4B2B-AA14-F7AC26E20BAAQ42060470-D520894C-AFFA-4E77-AC30-0FF58FF18703Q42113668-6E3C10A5-BED8-48BD-8D31-7229C55737CAQ47128524-809C5149-0A5C-4981-B33E-290B2D79247AQ47670541-541E9BCD-207E-4430-901B-B6ACD36B2B17Q48171670-28236953-3231-49F9-9638-257EAC32B32AQ55155177-D82E79C5-961E-4860-96CE-33006EBD05E4Q57795864-200AA2F6-1039-420F-AC66-39FC62FFF323Q58695596-3C6A6B4F-7437-4477-8CE5-74751CA253C8Q59133388-65599F8E-CF8C-465C-976C-1405572B3828
P2860
Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Somatic CEBPA mutations are a ...... milial acute myeloid leukemia.
@en
Somatic CEBPA mutations are a ...... milial acute myeloid leukemia.
@nl
type
label
Somatic CEBPA mutations are a ...... milial acute myeloid leukemia.
@en
Somatic CEBPA mutations are a ...... milial acute myeloid leukemia.
@nl
prefLabel
Somatic CEBPA mutations are a ...... milial acute myeloid leukemia.
@en
Somatic CEBPA mutations are a ...... milial acute myeloid leukemia.
@nl
P2093
P356
P1476
Somatic CEBPA mutations are a ...... milial acute myeloid leukemia.
@en
P2093
Beatrice U Mueller
Julian Schardt
Marianne Eyholzer
Simon Haefliger
Thomas Pabst
P304
P356
10.1200/JCO.2008.16.5563
P407
P577
2008-09-02T00:00:00Z